Pharmaceutical companies invest an average of $6.67 million in developing medical publications for blockbuster drugs, according to a new report, “Pharmaceutical Medical Publications: Winning Physician Support” (http://www.PharmaPublicationStrategy.com/), from pharmaceutical business intelligence firm Cutting Edge Information.
Insider wonders how much of this $6.67 million is spent on ghostwriting!
No comments:
Post a Comment